Aktionärsstruktur

Inhaber in %
Freefloat 0,84
Novartis AG 0,09
Sandoz Family Foundation 0,03
Novartis Foundation For Employee Participation 0,03
Government Pension Fund - Global (the) 0,02
Vanguard Health Care Fund 0,01
Vanguard Total International Stock Index Fund 0,01
Vanguard Developed Markets Index Fund 0,01
American Funds Europacific Growth Fund 0,01
American Funds Capital World Growth & Income Fund 0,01
Capital Income Builder 0,01
Robeco Capital Gr. Fds. - Bp European Premium Equities 0,00
Kempen European High Dividend Fund 0,00
Nn (l) - Global High Dividend 0,00
Privatdepot 4 0,00

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 0 0 0 0 0
Umsatz pro Mitarbeiter in Mio. EUR 359.672.692.442.719,00 401.051.184.986.789,00 403.725.864.989.119,00 397.510.840.034.739,00 40.581.793.626.553,00

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 3.732.248.765 22.867.845 2.533.862.185 27.488.696 350.580.054
Summe Anlagevermögen 9.054.635.625 99.075.977 1.002.466.659 999.768.785 1.091.320.032
Summe Aktiva 1.249.673.859 132.036.905 13.251.882.745 129.832.635 1.435.778.268

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 2.022.972.035 21.952.931 241.911.627 277.001.625 31.634.322
Summe Fremdkapital 545.732.453 54.837.783 564.033.596 574.984.235 660.032.532
Summe Eigenkapital 703.941.406 77.199.122 7.611.546.785 723.342.115 775.745.736
Summe Passiva 1.249.673.859 132.036.905 13.251.882.745 129.832.635 1.435.778.268

Adresse

Lichtstrasse 35, 4056 Basel
Telefon 41.61.324.11.11
Fax 41.61.324.80.01
Internet http://www.novartis.com

Management

Ameet Mallik
Head-Global Marketing, Value & Access
Andreas von Planta
Independent Non-Executive Director
Ann Marie Fudge
Independent Non-Executive Director
Bertrand Bodson
Chief Digital Officer
Charles L. Sawyers
Independent Non-Executive Director
Charlie Hough
VP & Global Head-Strategy
Charlotte Pamer-Wieser
Secretary
Dan Bar-Zohar
Global Head-Neuroscience Development
David Lebwohl
SVP & Franchise Global Program Head
Elizabeth Theophille
Chief Technology & Digital Officer
Enrico Cipro Vanni
Vice Chairman
Frans van Houten
Independent Non-Executive Director
Hans Jörg Reinhardt
Independent Non-Executive Chairman
Harry Werner Kirsch
Chief Financial Officer
James E. Bradner
Member-Executive Committee
Janneke van der Kamp
Member Executive Committee
Jeffrey Engelman
Vice President & Global Head-Oncology NIBR
John Tsai
Chief Medical Officer
Klaus Moosmayer
Chief Ethics Risk & Compliance Officer
Lilli Petruzzelli
Global Head-Immuno-Oncology
Mark Levick
Global Head
Mark Never
Head-Cluster Western Europe
Mary Elizabeth Doherty
Independent Non-Executive Director
Mimi Huizinga
VP & Head-Strategic Data
Nancy C. Andrews
Independent Non-Executive Director
Natacha Theytaz
Head-Internal Audit
Patrice Bula
Director
Samir Shah
Global Head-Investor Relations
Samit Hirawat
Head- Global Oncology Development
Shannon Thyme Klinger
Group General Counsel
Srikant T. Madhav Datar
Independent Non-Executive Director
Steffen Lang
Global Head-Technical Operations
Stephen Moran
Global Head-Strategy
Steven Baert
Head-Human Resources
Ton Büchner
Independent Non-Executive Director
Vasant Narasimhan
Chief Executive Officer
William Thomas Winters
Independent Non-Executive Director